Dimensional Fund Advisors’s Tempest Therapeutics TPST Stock Holding History
Bought
Maintained
Sold
Other funds holding TPST
SM
VVM
Dimensional Fund Advisors's TPST Position: Q2 2026 in Review
Dimensional Fund Advisors sold out of Tempest Therapeutics (TPST) in Q2 2026, closing a stake of 11,444 shares — an estimated $18.8K sold.
Dimensional Fund Advisors first reported a position in TPST in Q2 2016 and held it in 17 quarters. The position peaked at $280K in Q2 2019. 21 funds tracked by Wall St. Rank hold TPST as of Q2 2026.
- Dimensional Fund Advisors reported no remaining Tempest Therapeutics position as of Q2 2026 after selling out during the quarter.
- Dimensional Fund Advisors sold 11,444 Tempest Therapeutics shares in Q2 2026, an estimated $18.8K.
- Dimensional Fund Advisors first reported a position in Tempest Therapeutics in Q2 2016 and held it in 17 quarters.
- Dimensional Fund Advisors's Tempest Therapeutics position peaked at $280K in Q2 2019.
- 21 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q2 2026.
Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.